Back to search results

Endotype DIrected Treatment for OSA in Down Syndrome

Abroad (travel likely)RecruitingPHASE4

Conditions

Obstructive Sleep Apnea (OSA) · Down Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Arizona, Tucson, Arizona, United States

    Contact: Study coordinator (Natalie Provencio-Dean) · nataliep@arizona.edu · 520-403-6165

  • University of California San Diego, San Diego, California, United States

    Contact: Study coordinator (Jasmine Tinoco) · j1tinoco@health.ucsd.edu · 858-576-1700
    Contact: Principal Investigator (Rakesh Bhattacharjee)

  • University of Miami, Miami, Florida, United States

    Contact: Study coordinator (Ignacio Tapia) · itapia@miami.edu · 305-243-6162
    Contact: Principal Investigator (Ignacio Tapia)

  • Advocate Medical Group Adult Down Syndrome Center, Park Ridge, Illinois, United States

    Contact: Study coordinator (Alex Albers) · alexander.albers@aah.org · 920-288-3129
    Contact: Principal Investigator (Brian Chicoine)

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Ruth Bradford) · BRADFORD@chop.edu · 267-426-5747
    Contact: Principal Investigator (Chris Cielo)
Study leads

  • Daniel Combs, MD

    Principal Investigator

    University of Arizona

View source on ClinicalTrials.gov(opens in a new tab)